1	Constitutive	constitutive	_	_	_	_	_	_	_
2	nuclear	nuclear	_	_	_	_	_	_	_
3	NF-kappa	NF-kappa	_	_	_	_	_	_	_
4	B	B	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	monocyte	monocyte	_	_	_	_	_	_	_
10	lineage	lineage	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	monocytes	monocyte	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	nuclear	nuclear	_	_	_	_	_	_	_
6	factor	factor	_	_	_	_	_	_	_
7	NF-kappa	NF-kappa	_	_	_	_	_	_	_
8	B	B	_	_	_	_	_	_	_
9	has	have	_	_	_	_	_	_	_
10	been	be	_	_	_	_	_	_	_
11	invoked	invoke	_	_	_	_	_	_	_
12	as	as	_	_	_	_	_	_	_
13	an	an	_	_	_	_	_	_	_
14	important	important	_	_	_	_	_	_	_
15	transcription	transcription	_	_	_	_	_	_	_
16	factor	factor	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	expression	expression	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	cytokine	cytokine	_	_	_	_	_	_	_
22	genes	gene	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	cell-surface	cell-surface	_	_	_	_	_	_	_
26	receptors	receptor	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	in	in	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	expression	expression	_	_	_	_	_	_	_
31	of	of	_	_	_	_	_	_	_
32	human	human	_	_	_	_	_	_	_
33	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
34	virus	virus	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	such	such	_	_	_	_	_	_	_
3	cells	cell	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	DNA	DNA	_	_	_	_	_	_	_
6	binding	binding	_	_	_	_	_	_	_
7	activity	activity	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	NF-kappa	NF-kappa	_	_	_	_	_	_	_
10	B	B	_	_	_	_	_	_	_
11	can	can	_	_	_	_	_	_	_
12	be	be	_	_	_	_	_	_	_
13	detected	detect	_	_	_	_	_	_	_
14	without	without	_	_	_	_	_	_	_
15	intentional	intentional	_	_	_	_	_	_	_
16	stimulation	stimulation	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	our	our	_	_	_	_	_	_	_
3	studies	study	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	cells	cell	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	monocytic	monocytic	_	_	_	_	_	_	_
10	line	line	_	_	_	_	_	_	_
11	Mono	Mono	_	_	_	_	_	_	_
12	Mac	Mac	_	_	_	_	_	_	_
13	6	6	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	cultured	culture	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	medium	medium	_	_	_	_	_	_	_
18	containing	contain	_	_	_	_	_	_	_
19	fetal-calf	fetal-calf	_	_	_	_	_	_	_
20	serum	serum	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	low	low	_	_	_	_	_	_	_
23	levels	level	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	lipopolysaccharide	lipopolysaccharide	_	_	_	_	_	_	_
26	(	(	_	_	_	_	_	_	_
27	LPS	LPS	_	_	_	_	_	_	_
28	)	)	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	also	also	_	_	_	_	_	_	_
31	exhibit	exhibit	_	_	_	_	_	_	_
32	such	such	_	_	_	_	_	_	_
33	‘	`	_	_	_	_	_	_	_
34	constitutive	constitutive	_	_	_	_	_	_	_
35	’	'	_	_	_	_	_	_	_
36	NF-kappa	NF-kappa	_	_	_	_	_	_	_
37	B	B	_	_	_	_	_	_	_
38	,	,	_	_	_	_	_	_	_
39	as	as	_	_	_	_	_	_	_
40	demonstrated	demonstrate	_	_	_	_	_	_	_
41	by	by	_	_	_	_	_	_	_
42	mobility-shift	mobility-shift	_	_	_	_	_	_	_
43	analysis	analysis	_	_	_	_	_	_	_
44	of	of	_	_	_	_	_	_	_
45	nuclear	nuclear	_	_	_	_	_	_	_
46	extracts	extract	_	_	_	_	_	_	_
47	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	nuclear	nuclear	_	_	_	_	_	_	_
3	NF-kappa	NF-kappa	_	_	_	_	_	_	_
4	B	B	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	still	still	_	_	_	_	_	_	_
7	present	present	_	_	_	_	_	_	_
8	when	when	_	_	_	_	_	_	_
9	contaminant	contaminant	_	_	_	_	_	_	_
10	LPS	lps	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	removed	remove	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	ultrafiltration	ultrafiltration	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	when	when	_	_	_	_	_	_	_
17	serum	serum	_	_	_	_	_	_	_
18	was	be	_	_	_	_	_	_	_
19	omitted	omit	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Protein-DNA	protein-dna	_	_	_	_	_	_	_
2	complexes	complex	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	constitutive	constitutive	_	_	_	_	_	_	_
5	NF-kappa	NF-kappa	_	_	_	_	_	_	_
6	B	B	_	_	_	_	_	_	_
7	are	be	_	_	_	_	_	_	_
8	similar	similar	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	mobility	mobility	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	LPS-induced	lps-induced	_	_	_	_	_	_	_
14	NF-kappa	NF-kappa	_	_	_	_	_	_	_
15	B	B	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	both	both	_	_	_	_	_	_	_
18	are	be	_	_	_	_	_	_	_
19	recognized	recognize	_	_	_	_	_	_	_
20	by	by	_	_	_	_	_	_	_
21	an	an	_	_	_	_	_	_	_
22	antibody	antibody	_	_	_	_	_	_	_
23	specific	specific	_	_	_	_	_	_	_
24	to	to	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	p50	p50	_	_	_	_	_	_	_
27	subunit	subunit	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	NF-kappa	NF-kappa	_	_	_	_	_	_	_
30	B.	B.	_	_	_	_	_	_	_
31	By	by	_	_	_	_	_	_	_
32	contrast	contrast	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	treatment	treatment	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	cells	cell	_	_	_	_	_	_	_
37	with	with	_	_	_	_	_	_	_
38	pyrrolidine	pyrrolidine	_	_	_	_	_	_	_
39	dithiocarbamate	dithiocarbamate	_	_	_	_	_	_	_
40	(	(	_	_	_	_	_	_	_
41	PDTC	PDTC	_	_	_	_	_	_	_
42	)	)	_	_	_	_	_	_	_
43	will	will	_	_	_	_	_	_	_
44	only	only	_	_	_	_	_	_	_
45	block	block	_	_	_	_	_	_	_
46	LPS-induced	lps-induced	_	_	_	_	_	_	_
47	NF-kappa	NF-kappa	_	_	_	_	_	_	_
48	B	B	_	_	_	_	_	_	_
49	,	,	_	_	_	_	_	_	_
50	but	but	_	_	_	_	_	_	_
51	not	not	_	_	_	_	_	_	_
52	the	the	_	_	_	_	_	_	_
53	constitutive	constitutive	_	_	_	_	_	_	_
54	binding	bind	_	_	_	_	_	_	_
55	protein	protein	_	_	_	_	_	_	_
56	.	.	_	_	_	_	_	_	_

1	Using	use	_	_	_	_	_	_	_
2	LPS-free	lps-free	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	serum-free	serum-free	_	_	_	_	_	_	_
5	conditions	condition	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	constitutive	constitutive	_	_	_	_	_	_	_
8	NF-kappa	NF-kappa	_	_	_	_	_	_	_
9	B	B	_	_	_	_	_	_	_
10	can	can	_	_	_	_	_	_	_
11	be	be	_	_	_	_	_	_	_
12	detected	detect	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	different	different	_	_	_	_	_	_	_
15	cell	cell	_	_	_	_	_	_	_
16	lines	line	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	monocytic	monocytic	_	_	_	_	_	_	_
20	lineage	lineage	_	_	_	_	_	_	_
21	(	(	_	_	_	_	_	_	_
22	HL60	HL60	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	U937	U937	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	THP-1	THP-1	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	Mono	Mono	_	_	_	_	_	_	_
29	Mac	Mac	_	_	_	_	_	_	_
30	1	1	_	_	_	_	_	_	_
31	and	and	_	_	_	_	_	_	_
32	Mono	Mono	_	_	_	_	_	_	_
33	Mac	Mac	_	_	_	_	_	_	_
34	6	6	_	_	_	_	_	_	_
35	)	)	_	_	_	_	_	_	_
36	,	,	_	_	_	_	_	_	_
37	but	but	_	_	_	_	_	_	_
38	not	not	_	_	_	_	_	_	_
39	in	in	_	_	_	_	_	_	_
40	Molt	Molt	_	_	_	_	_	_	_
41	4	4	_	_	_	_	_	_	_
42	T	t	_	_	_	_	_	_	_
43	cells	cell	_	_	_	_	_	_	_
44	or	or	_	_	_	_	_	_	_
45	K562	k562	_	_	_	_	_	_	_
46	stem	stem	_	_	_	_	_	_	_
47	cells	cell	_	_	_	_	_	_	_
48	.	.	_	_	_	_	_	_	_

1	When	when	_	_	_	_	_	_	_
2	ordered	order	_	_	_	_	_	_	_
3	according	accord	_	_	_	_	_	_	_
4	to	to	_	_	_	_	_	_	_
5	stage	stage	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	maturation	maturation	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	amount	amount	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	constitutive	constitutive	_	_	_	_	_	_	_
13	NF-kappa	NF-kappa	_	_	_	_	_	_	_
14	B	B	_	_	_	_	_	_	_
15	was	be	_	_	_	_	_	_	_
16	not	not	_	_	_	_	_	_	_
17	increased	increase	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	more	more	_	_	_	_	_	_	_
20	mature	mature	_	_	_	_	_	_	_
21	cell	cell	_	_	_	_	_	_	_
22	lines	line	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	when	when	_	_	_	_	_	_	_
4	inducing	induce	_	_	_	_	_	_	_
5	differentiation	differentiation	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	Mono	Mono	_	_	_	_	_	_	_
8	Mac	Mac	_	_	_	_	_	_	_
9	6	6	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	with	with	_	_	_	_	_	_	_
13	vitamin	vitamin	_	_	_	_	_	_	_
14	D3	d3	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	no	no	_	_	_	_	_	_	_
17	change	change	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	constitutive	constitutive	_	_	_	_	_	_	_
20	or	or	_	_	_	_	_	_	_
21	inducible	inducible	_	_	_	_	_	_	_
22	NF-kappa	NF-kappa	_	_	_	_	_	_	_
23	B	B	_	_	_	_	_	_	_
24	can	can	_	_	_	_	_	_	_
25	be	be	_	_	_	_	_	_	_
26	detected	detect	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Analysis	Analysis	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	primary	primary	_	_	_	_	_	_	_
4	cells	cell	_	_	_	_	_	_	_
5	revealed	reveal	_	_	_	_	_	_	_
6	substantial	substantial	_	_	_	_	_	_	_
7	constitutive	constitutive	_	_	_	_	_	_	_
8	NF-kappa	NF-kappa	_	_	_	_	_	_	_
9	B-binding	b-binding	_	_	_	_	_	_	_
10	activity	activity	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	blood	blood	_	_	_	_	_	_	_
13	monocytes	monocyte	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	pleural	pleural	_	_	_	_	_	_	_
16	macrophages	macrophage	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	alveolar	alveolar	_	_	_	_	_	_	_
19	macrophages	macrophage	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	constitutive	constitutive	_	_	_	_	_	_	_
3	NF-kappa	NF-kappa	_	_	_	_	_	_	_
4	B	B	_	_	_	_	_	_	_
5	appears	appear	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	be	be	_	_	_	_	_	_	_
8	functionally	functionally	_	_	_	_	_	_	_
9	active	active	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	since	since	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	low	low	_	_	_	_	_	_	_
14	level	level	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	tumour	tumour	_	_	_	_	_	_	_
17	necrosis	necrosis	_	_	_	_	_	_	_
18	factor	factor	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	TNF	TNF	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	transcript	transcript	_	_	_	_	_	_	_
23	is	be	_	_	_	_	_	_	_
24	detectable	detectable	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	monocytes	monocyte	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	this	this	_	_	_	_	_	_	_
30	level	level	_	_	_	_	_	_	_
31	can	can	_	_	_	_	_	_	_
32	be	be	_	_	_	_	_	_	_
33	increased	increase	_	_	_	_	_	_	_
34	by	by	_	_	_	_	_	_	_
35	blocking	block	_	_	_	_	_	_	_
36	transcript	transcript	_	_	_	_	_	_	_
37	degradation	degradation	_	_	_	_	_	_	_
38	using	use	_	_	_	_	_	_	_
39	cycloheximide	cycloheximide	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	level	level	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	constitutive	constitutive	_	_	_	_	_	_	_
5	NF-kappa	NF-kappa	_	_	_	_	_	_	_
6	B	B	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	these	these	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	variable	variable	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	frequently	frequently	_	_	_	_	_	_	_
15	found	find	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	be	be	_	_	_	_	_	_	_
18	lower	low	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	more	more	_	_	_	_	_	_	_
22	mature	mature	_	_	_	_	_	_	_
23	macrophages	macrophage	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Constitutive	constitutive	_	_	_	_	_	_	_
2	NF-kappa	NF-kappa	_	_	_	_	_	_	_
3	B	B	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	not	not	_	_	_	_	_	_	_
6	maintained	maintain	_	_	_	_	_	_	_
7	by	by	_	_	_	_	_	_	_
8	autocrine	autocrine	_	_	_	_	_	_	_
9	action	action	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	cytokines	cytokine	_	_	_	_	_	_	_
12	TNF	TNF	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	interleukin	interleukin	_	_	_	_	_	_	_
15	6	6	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	interleukin	interleukin	_	_	_	_	_	_	_
18	10	10	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	granulocyte-macrophage	granulocyte-macrophage	_	_	_	_	_	_	_
21	colony-stimulating	colony-stimulating	_	_	_	_	_	_	_
22	factor	factor	_	_	_	_	_	_	_
23	or	or	_	_	_	_	_	_	_
24	macrophage	macrophage	_	_	_	_	_	_	_
25	colony-stimulating	colony-stimulating	_	_	_	_	_	_	_
26	factor	factor	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	since	since	_	_	_	_	_	_	_
29	neutralizing	neutralize	_	_	_	_	_	_	_
30	antibodies	antibody	_	_	_	_	_	_	_
31	did	do	_	_	_	_	_	_	_
32	not	not	_	_	_	_	_	_	_
33	reduce	reduce	_	_	_	_	_	_	_
34	constitutive	constitutive	_	_	_	_	_	_	_
35	DNA-binding	dna-binding	_	_	_	_	_	_	_
36	activity	activity	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	blockade	blockade	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	prostaglandin	prostaglandin	_	_	_	_	_	_	_
6	or	or	_	_	_	_	_	_	_
7	leukotriene	leukotriene	_	_	_	_	_	_	_
8	biosynthesis	biosynthesis	_	_	_	_	_	_	_
9	did	do	_	_	_	_	_	_	_
10	not	not	_	_	_	_	_	_	_
11	affect	affect	_	_	_	_	_	_	_
12	constitutive	constitutive	_	_	_	_	_	_	_
13	NF-kappa	NF-kappa	_	_	_	_	_	_	_
14	B.	B.	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	ABSTRACT	ABSTRACT	_	_	_	_	_	_	_
17	TRUNCATED	truncated	_	_	_	_	_	_	_
18	AT	at	_	_	_	_	_	_	_
19	400	400	_	_	_	_	_	_	_
20	WORDS	words	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_

